Lindbrook Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $48.4K | Sell |
367
-68
| -16% | -$8.97K | ﹤0.01% | 1026 |
|
|
2024
Q4 | $36.3K | Buy |
435
+65
| +18% | +$5.43K | ﹤0.01% | 951 |
|
|
2024
Q3 | $27.1K | Buy |
370
+35
| +10% | +$2.56K | ﹤0.01% | 1127 |
|
|
2024
Q2 | $22.9K | Sell |
335
-53
| -14% | -$3.63K | ﹤0.01% | 1163 |
|
|
2024
Q1 | $26.9K | Hold |
388
| – | – | ﹤0.01% | 1064 |
|
|
2023
Q4 | $27.8K | Sell |
388
-7
| -2% | -$501 | ﹤0.01% | 1007 |
|
|
2023
Q3 | $20.6K | Buy |
395
+71
| +22% | +$3.7K | ﹤0.01% | 1049 |
|
|
2023
Q2 | $20.5K | Buy |
324
+31
| +11% | +$1.96K | ﹤0.01% | 1074 |
|
|
2023
Q1 | $15.9K | Sell |
293
-11
| -4% | -$596 | ﹤0.01% | 1187 |
|
|
2022
Q4 | $16.1K | Sell |
304
-181
| -37% | -$9.58K | ﹤0.01% | 1174 |
|
|
2022
Q3 | $23K | Buy |
485
+122
| +34% | +$5.79K | ﹤0.01% | 932 |
|
|
2022
Q2 | $21K | Buy |
363
+296
| +442% | +$17.1K | ﹤0.01% | 957 |
|
|
2022
Q1 | $4K | Buy |
+67
| New | +$4K | ﹤0.01% | 1759 |
|